Amir Elsebaei is an experienced Market Access associate director currently serving as the Rare Disease Market Access Lead at AstraZeneca-Alexion. With a background in oncology and rare diseases, Amir has held key roles in several leading biotechnology companies, including Genzyme Genetics and Amgen. Their expertise encompasses market access strategy, pricing, and building strategic partnerships with health authorities. Amir obtained an Associate's degree from INSEAD and a Bachelor's degree in Pharmaceutical Sciences from Helwan University Cairo.
Location
Cairo, Egypt
This person is not in the org chart
This person is not in any teams
This person is not in any offices